Humanized L243 antibodies
Humanized antibodies are provided that specifically bind HLA-DR. The antibodies recognize the epitope recognized by the murine monoclonal antibody L243. Processes for preparing such antibodies, pharmaceutical compositions containing such antibodies, and clinical therapeutic and diagnostic, as well as research-related uses for such antibodies, are provided.
Immunomedics, Inc.
A A C C A C A A C A A C C A A C A A A A C C C A C C A C C A C A
A61K A61P C07K C07K A61K C07K A61P A61P C07K A61K A61K C07K C07K A61P A61K C07K A61K A61P A61K A61P C07K C07K C07K A61K C07K C07K A61P C07K C07K A61K C07K A61P
inventional inventional additional additional additional additional inventional inventional additional inventional inventional additional additional inventional additional inventional inventional inventional inventional inventional additional additional inventional inventional inventional inventional inventional additional additional inventional inventional inventional
Hans J. Zhengxing David M. Chien-Hsing
Hansen Qu Goldenberg Chang